Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival--a retrospective multi-centre cohort study.

MLA

Schwentner, L., et al. “Triple-Negative Breast Cancer: The Impact of Guideline-Adherent Adjuvant Treatment on Survival--a Retrospective Multi-Centre Cohort Study.” Breast Cancer Research and Treatment, vol. 132, no. 3, Apr. 2012, pp. 1073–80. EBSCOhost, https://doi.org/10.1007/s10549-011-1935-y.

APA

Schwentner, L., Wolters, R., Koretz, K., Wischnewsky, M. B., Kreienberg, R., Rottscholl, R., & Wöckel, A. (2012). Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival--a retrospective multi-centre cohort study. Breast Cancer Research and Treatment, 132(3), 1073–1080. https://doi.org/10.1007/s10549-011-1935-y

Chicago

Schwentner, L, R Wolters, K Koretz, M B Wischnewsky, R Kreienberg, R Rottscholl, and A Wöckel. 2012. “Triple-Negative Breast Cancer: The Impact of Guideline-Adherent Adjuvant Treatment on Survival--a Retrospective Multi-Centre Cohort Study.” Breast Cancer Research and Treatment 132 (3): 1073–80. doi:10.1007/s10549-011-1935-y.